Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... promising anemia treatment alternative for patients in this population, with a different immunogenicity profile than other erythropoiesis-stimulating agents," said Iain C. Macdougall, M.D., ...
2009 NOV 16 ... of highly-refined, soluble bovine dermal collagen (Type I), which is modified to reduce immunogenicity and promote its usefulness in wound settings. ExcellagenXL is planned for physician use ...
2009 NOV 16 ... the optimal dose for further development based on the safety, tolerability, and immunogenicity of the vaccine. The trial will evaluate three different doses of the vaccine in ...
2009 NOV 23 ... subunit vaccines have shown promise but require the use of adjuvants to enhance their immunogenicity. Using the protective mycobacterial antigen Rv3019c, we have evaluated the induction of ...
2009 NOV 16 ... Besides the VaxiSomeTM technology, which is an adjuvant system for enhancing the immunogenicity of vaccines and immunotherapeutics, the company has two distinct product areas. ...
2009 NOV 18 ... are safe for the correction of moderate to severe facial folds and wrinkles, with no immunogenicity or keloid formation and only mild to moderate AEs occurring around the injection site." ...
2009 NOV 10 ... from October 29 - November 1, 2009. Poster presentation: "Safety and Immunogenicity of a Recombinant Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine in ...
2009 NOV 23 ... double-blind, active-controlled study is evaluating the safety, tolerability and immunogenicity of two different doses of Novavax's trivalent seasonal influenza VLP vaccine compared ...
2009 NOV 16 ... company, announced that the Company made a poster presentation on the "Safety and Immunogenicity of a Recombinant Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine in ...
2009 NOV 23 ... combined with crystallographic structural data may enable prediction of the relative immunogenicity of individual donor/recipient HLA mismatches. Multiple sera from 32 highly sensitized ...
2009 NOV 24 ... colleagues. The researchers concluded: "Pneumococcal vaccines retain their immunogenicity when administered into the eighth decade of life, but a second dose, when assessed by ...
2009 NOV 24 ... The researchers concluded: "However, studies addressing the safety, reactogenicity, and immunogenicity of rotavirus vaccines in an HIV-infected population are urgently needed." ...
2009 NOV 16 ... According to a study from Stockholm, Sweden, "Immunogenicity of tumor-associated antigens (TAA) is often weak because many TAA are autoantigens for ...
2009 NOV 23 ... vaccines against typhoid fever are available, improvements are desired in dosage, immunogenicity and tolerability. Emergent BioSolutions Inc is developing M-01ZH09, a single-dose oral ...
2009 NOV 17 ... degradation of two human CXC chemokines in vitro, the high sequence conservation, the immunogenicity of the protein in humans and the shown protection in animal studies suggest that Spy0416 ...
2009 NOV 16 ... mutation in DIII of the DENV-4 E protein was responsible for reduced infectivity and immunogenicity in rhesus monkeys," wrote G. Anez and colleagues, National Institutes of Health. ...
2009 NOV 23 ... focus on the underlying pathways leading to antibody formation are warranted to predict immunogenicity of these expensive biological agents and treatment outcomes." Radstake and ...
2009 NOV 16 ... to metastatic breast cancer tumors, one needs a drug of high potency and reduced immunogenicity. Thus, we bioengineered a novel bispecific ligand-directed toxin (BLT) targeted by dual ...
2009 NOV 23 ... trials with measured clinical endpoints in MS patients to establish safety, efficacy and immunogenicity in this patient population. Keywords: , Health, Pharmaceutical, ...
2009 NOV 16 ... in 2012 based on efficacy in children 5-17 months of age. Additional safety and immunogenicity data from the infant population will be submitted soon thereafter, followed by efficacy ...
